‘Regrettable, if understandable’: PBS tightens GLP-1 RA prescribing rules
Associate Professor Gary Kilov said the PBAC had 'telegraphed' the changes for over a year but the wording had not been finalised until recently.
Doctors prescribing GLP-1 receptor agonists now require telephone or electronic authority when initiating therapy for all PBS indications.
On 1 June, health officials tightened the rules for semaglutide (Ozempic) and dulaglutide (Trulicity) as part of a crackdown on prescribing outside of the PBS rules, while also removing restrictions for other type 2 diabetes medications.
